The Alzheimerâs and Dementia Program Data Reporting Tool (ADP-DRT) is needed in order to:
â¢Collect data for performance measures used in the justification of the budget to Congress and by program, state and national decision makers.
â¢Effectively manage the ACLâs Alzheimerâs Disease Program at the federal, state and local levels.
â¢Advocate at the federal and state levels for more effective and efficient supports and services for persons with Alzheimerâs disease and their caregivers.
The ADP-DRT collects information about the delivery of supports and services by the Administration for Community Living (ACL) Alzheimerâs Disease Program grantees, including basic demographic information about service recipients and spending on direct services and administrative expenses.
The Older Americanâs Act requires ACL to evaluate âdemonstration projects that support the objectives of this Act, including activities to bring effective demonstration projects to scale with a prioritization of projects that address the needs of under served populations, and promote partnerships among aging services, community-based organizations, and Medicare and Medicaid providers, plans, and health (including public health) systems. (Section 201 (42 U.S.C. 3011) Sec. 127. Research and Evaluation). To fulfill the evaluation requirements and allow for optimal federal and state-level management of the program, specific information must be collected from grantees, including the following:
A. The number of persons with Alzheimerâs disease or related dementia or at high risk of dementia and/or their caregivers served by the program and their respective demographic characteristics.
B. The number of professionals trained in dementia education, care and best practices.
C. Information about grant funds spent on direct services, program administration costs and general organizational administrative costs.
D. The provision of direct services to persons with Alzheimerâs disease or related dementia or at high risk of dementia and/or their caregivers.
Information from the ADP-DRT will be provided to: federal and state legislators; state agencies on aging; national, state and local organizations with an interest in Alzheimerâs disease and related dementia and long-term care issues; current and future ACL Alzheimerâs Disease Program grantees; and private citizens who request it. Information will be posted on ACLâs National Alzheimerâs and Dementia Resource Center (NADRC) website.
There is a program change increase of 1346 annual burden hours. The annual reporting burden hour estimates have increased from 983 to 2,329.
The following reasons account for the change in burden hour estimates:
⢠The new estimates are for 90 grants, rather than the 38 grants from the previous ADP-DRT approval, a 136% increase in the number of grants.
⢠Although, for data set approved in 2016, it was anticipated that grantee respondents would spend 25.88 hours reporting annually, the actual number of hours spent (local partners and grantee combined), as reported by the current ADP grantees consulted, was 19.92 hours annually per grant.
The following reasons account for the change in burden cost estimates:
⢠The new estimates are for 90 grants, rather than the 38 grants from the previous ADP-DRT approval. This also include data collection from 180 local partners, rather than 76 local partners from the previous ADP-DRT approval
⢠The pay grades and pay rates for local partner and grantee staff increased between 2016 and 2020.
⢠The annualized cost to the federal government increased due to increased contractor costs to analyze the data of the increased in the number of grantees and a pay grade increase for the federal project officer.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.